SGB to supply Convidicea vaccine


Under the agreement, Solution Biologics will supply 3.5 million doses of the vaccine to MoH.

KUALA LUMPU: Solution Group Bhd (SGB), through its wholly-owned subsidiary Solution Biologics Sdn Bhd, has entered into a supply agreement with the government, represented by the Health Ministry (MoH), to supply Convidicea, a recombinant novel coronavirus vaccine.

Under the agreement, Solution Biologics will supply 3.5 million doses of the vaccine to MoH.

Solution Biologics has also been granted the exclusive right to register, manufacture and commercialise the vaccine in Malaysia, the company said in a statement.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Next In Business News

Bitcoin rallies past key $40,000
PBOC: China will maintain prudent, flexible monetary policy
Bank Rakyat launches entrepreneur programme
CPO futures seen trading with upward bias next week
As scrutiny mounts, crypto exchange Binance to wind down derivatives in Europe
Oil price climbs, notches fourth monthly gain on growing demand
Chevron tops profit estimates, joins share buyback stampede
Indian billionaire's new airline may give Boeing a chance to regain lost ground
Global Markets: US stocks slip, US# has worst week in almost two months
Post-pandemic comeback of Malaysian REITs

Stories You'll Enjoy


Vouchers